Literature DB >> 7138564

Membrane alterations associated with progressive adriamycin resistance.

C Wheeler, R Rader, D Kessel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7138564     DOI： 10.1016/0006-2952(82)90723-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  15 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells.

Authors:  D Roberts; T Lee; E Parganas; L Wiggins; J Yalowich; R Ashmun
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Immobilization of a primary amine-containing drug, adriamycin. Coupling to crosslinked polyvinyl alcohol and mechanistic comparison of hydrolytic stability.

Authors:  L B Wingard; K Narasimhan
Journal:  Appl Biochem Biotechnol       Date:  1988-11       Impact factor: 2.926

4.  Study of the properties of doxorubicin-resistant cells affected by acute leucosis.

Authors:  Marina Yu Skorkina; Elena A Shamray; Victoria A Salo; Anatoly S Buchelnikov; Maxim P Evstigneev
Journal:  J Bioenerg Biomembr       Date:  2017-12-19       Impact factor: 2.945

Review 5.  Tumour cell resistance to anthracyclines--a review.

Authors:  S Kaye; S Merry
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 6.  Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?

Authors:  Wing-Kee Lee; Richard N Kolesnick
Journal:  Cell Signal       Date:  2017-07-04       Impact factor: 4.315

Review 7.  Pharmacokinetics of anticancer drugs in children.

Authors:  W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

8.  Expression of cell surface P-glycoprotein by an adriamycin-resistant murine fibrosarcoma.

Authors:  R Giavazzi; N Kartner; I R Hart
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

9.  Characterization of cellular lipids in doxorubicin-sensitive and -resistant P388 mouse leukemia cells.

Authors:  W M Holleran; M W DeGregorio; R Ganapathi; J R Wilbur; B A Macher
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

10.  Detection of drug resistance in human ovarian carcinoma.

Authors:  M Volm; T Efferth; M Bak; J Mattern
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.